Cargando…

Application of a novel prognostic invasive lesion index in ductal carcinoma in situ with minimal invasion of the breast

Multiple invasive foci has been shown to increase the risk of lymph node metastasis (LNM) in early breast cancer, but its prognostic implication remains unknown. We aimed to identify the prognostic value of the number of invasive foci in ductal carcinoma in situ with minimal invasion of the breast (...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xiaofang, Ye, Feng, Li, Mei, Yu, Ping, Xiao, Xiangsheng, Tang, Hailin, Xie, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673919/
https://www.ncbi.nlm.nih.gov/pubmed/28980458
http://dx.doi.org/10.1002/cam4.1175
_version_ 1783276665087983616
author He, Xiaofang
Ye, Feng
Li, Mei
Yu, Ping
Xiao, Xiangsheng
Tang, Hailin
Xie, Xiaoming
author_facet He, Xiaofang
Ye, Feng
Li, Mei
Yu, Ping
Xiao, Xiangsheng
Tang, Hailin
Xie, Xiaoming
author_sort He, Xiaofang
collection PubMed
description Multiple invasive foci has been shown to increase the risk of lymph node metastasis (LNM) in early breast cancer, but its prognostic implication remains unknown. We aimed to identify the prognostic value of the number of invasive foci in ductal carcinoma in situ with minimal invasion of the breast (DCIS‐MI), and further establish a prognostic invasive lesion index (ILI). A total of 193 patients with DCIS‐MI (the invasive component was up to 10 mm in diameter) were included. Univariate and multivariate analysis (logistic regression) were used to evaluate the predictive value of the number of invasive foci in LNM. The Kaplan–Meier curve was used for survival analysis. More than five invasive foci was an independent predictor for LNM (OR, 2.67, 95% CI, 1.12–6.33, P = 0.026), and associated with significantly shorter disease‐free survival (DFS) and overall survival (OS) compared with no more than five invasive foci (mean DFS 123.8 vs. 148.0 months, P = 0.002; and mean OS 133.5 vs. 151.4 months, P = 0.025). The ILI was established by the sum scores of the number of invasive foci and the invasive component size, having an optimal cut‐off point of 5.5 scores. The high‐ILI group (ILI >5 scores) had a higher incidence of LNM (23.6% vs. 6.9%) and worse prognosis than the low‐ILI group (ILI ≤5 scores). In conclusion, more than five invasive foci was an independent predictor for LNM and an unfavorable prognostic parameter. The ILI could potentially be used to predict survival prognosis in patients with DCIS‐MI.
format Online
Article
Text
id pubmed-5673919
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56739192017-11-15 Application of a novel prognostic invasive lesion index in ductal carcinoma in situ with minimal invasion of the breast He, Xiaofang Ye, Feng Li, Mei Yu, Ping Xiao, Xiangsheng Tang, Hailin Xie, Xiaoming Cancer Med Clinical Cancer Research Multiple invasive foci has been shown to increase the risk of lymph node metastasis (LNM) in early breast cancer, but its prognostic implication remains unknown. We aimed to identify the prognostic value of the number of invasive foci in ductal carcinoma in situ with minimal invasion of the breast (DCIS‐MI), and further establish a prognostic invasive lesion index (ILI). A total of 193 patients with DCIS‐MI (the invasive component was up to 10 mm in diameter) were included. Univariate and multivariate analysis (logistic regression) were used to evaluate the predictive value of the number of invasive foci in LNM. The Kaplan–Meier curve was used for survival analysis. More than five invasive foci was an independent predictor for LNM (OR, 2.67, 95% CI, 1.12–6.33, P = 0.026), and associated with significantly shorter disease‐free survival (DFS) and overall survival (OS) compared with no more than five invasive foci (mean DFS 123.8 vs. 148.0 months, P = 0.002; and mean OS 133.5 vs. 151.4 months, P = 0.025). The ILI was established by the sum scores of the number of invasive foci and the invasive component size, having an optimal cut‐off point of 5.5 scores. The high‐ILI group (ILI >5 scores) had a higher incidence of LNM (23.6% vs. 6.9%) and worse prognosis than the low‐ILI group (ILI ≤5 scores). In conclusion, more than five invasive foci was an independent predictor for LNM and an unfavorable prognostic parameter. The ILI could potentially be used to predict survival prognosis in patients with DCIS‐MI. John Wiley and Sons Inc. 2017-10-04 /pmc/articles/PMC5673919/ /pubmed/28980458 http://dx.doi.org/10.1002/cam4.1175 Text en © 2017 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
He, Xiaofang
Ye, Feng
Li, Mei
Yu, Ping
Xiao, Xiangsheng
Tang, Hailin
Xie, Xiaoming
Application of a novel prognostic invasive lesion index in ductal carcinoma in situ with minimal invasion of the breast
title Application of a novel prognostic invasive lesion index in ductal carcinoma in situ with minimal invasion of the breast
title_full Application of a novel prognostic invasive lesion index in ductal carcinoma in situ with minimal invasion of the breast
title_fullStr Application of a novel prognostic invasive lesion index in ductal carcinoma in situ with minimal invasion of the breast
title_full_unstemmed Application of a novel prognostic invasive lesion index in ductal carcinoma in situ with minimal invasion of the breast
title_short Application of a novel prognostic invasive lesion index in ductal carcinoma in situ with minimal invasion of the breast
title_sort application of a novel prognostic invasive lesion index in ductal carcinoma in situ with minimal invasion of the breast
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673919/
https://www.ncbi.nlm.nih.gov/pubmed/28980458
http://dx.doi.org/10.1002/cam4.1175
work_keys_str_mv AT hexiaofang applicationofanovelprognosticinvasivelesionindexinductalcarcinomainsituwithminimalinvasionofthebreast
AT yefeng applicationofanovelprognosticinvasivelesionindexinductalcarcinomainsituwithminimalinvasionofthebreast
AT limei applicationofanovelprognosticinvasivelesionindexinductalcarcinomainsituwithminimalinvasionofthebreast
AT yuping applicationofanovelprognosticinvasivelesionindexinductalcarcinomainsituwithminimalinvasionofthebreast
AT xiaoxiangsheng applicationofanovelprognosticinvasivelesionindexinductalcarcinomainsituwithminimalinvasionofthebreast
AT tanghailin applicationofanovelprognosticinvasivelesionindexinductalcarcinomainsituwithminimalinvasionofthebreast
AT xiexiaoming applicationofanovelprognosticinvasivelesionindexinductalcarcinomainsituwithminimalinvasionofthebreast